| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Chief Commercial Officer
1 company
Jeffrey Dierks last filed a Form 4 in March 2025, as Chief Commercial Officer at HRMY. From June 2021 to March 2025, the filings on record show 0 open-market purchases and 23 sales. Jeffrey Dierks's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Jeffrey Dierks a middling insider score of 62/100, based on 28 past trades. Over a 12-month horizon, 53.6% of those trades were profitable, with an average 12-month return of -1.5%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 11,979 | $32.00 | $383,328.00 | - | -6.9% | +2.3% | |
| Mar 8, 2024 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 194 | $32.00 | $6,208.00 | - | -1.8% | +8.3% | |
| Oct 3, 2022 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 12,173 | $44.68 | $543,915.98 | - | +16.7% | -28.7% | |
| Aug 22, 2022 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 28,971 | $47.00 | $1,361,727.44 | - | +22.2% | -30.4% | |
| Apr 1, 2022 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 14,471 | $49.63 | $718,170.08 | - | -2.4% | -34.7% | |
| Mar 1, 2022 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 14,910 | $40.01 | $596,610.73 | - | +8.8% | +6.9% | |
| Feb 17, 2022 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 8,518 | $40.03 | $341,014.72 | - | +1.7% | +25.7% | |
| Jan 6, 2022 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 6,125 | $40.37 | $247,257.80 | - | +22.1% | +32.6% | |
| Nov 1, 2021 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 10,000 | $41.67 | $416,739.50 | - | -16.6% | +37.8% | |
| Sep 7, 2021 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $37.00 | $185,000.00 | - | -3.7% | +21.9% |